0.00
Eliem Therapeutics Inc (ELYM) 最新ニュース
Eliem Therapeutics, Inc. (NASDAQ:ELYM) Shares Bought by JPMorgan Chase & Co. - Defense World
Barclays PLC Acquires 36,316 Shares of Eliem Therapeutics, Inc. (NASDAQ:ELYM) - Defense World
Jane Street Group LLC Purchases New Position in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - Defense World
Eliem Therapeutics Enters into Exclusive Licensing Agreement with Beijing Mabworks Biotech - Defense World
State Street Corp Has $1.60 Million Holdings in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - Defense World
Eliem Therapeutics stock hits 52-week low at $1.86 amid market shifts - Investing.com Australia
Eliem Therapeutics stock hits 52-week low at $1.86 amid market shifts By Investing.com - Investing.com South Africa
Financial Analysis: TransCode Therapeutics (NASDAQ:RNAZ) & Eliem Therapeutics (NASDAQ:ELYM) - Defense World
Eliem Therapeutics, Inc. (NASDAQ:ELYM) Holdings Boosted by Charles Schwab Investment Management Inc. - Defense World
The Manufacturers Life Insurance Company Acquires Shares of 49,524 Eliem Therapeutics, Inc. (NASDAQ:ELYM) - Defense World
590,946 Shares in Eliem Therapeutics, Inc. (NASDAQ:ELYM) Acquired by Point72 Asset Management L.P. - MarketBeat
Janus Henderson Group PLC Has $18.30 Million Stake in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - MarketBeat
Samsara BioCapital LLC Has $13.28 Million Stake in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - MarketBeat
Parkman Healthcare Partners LLC Takes Position in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - MarketBeat
Ally Bridge Group NY LLC Purchases 729,292 Shares of Eliem Therapeutics, Inc. (NASDAQ:ELYM) - MarketBeat
Great Point Partners LLC Buys New Stake in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - MarketBeat
Eliem Therapeutics To Acquire Tenet Medicines - Contract Pharma
How To Trade (CLYM) - Stock Traders Daily
Climb Bio to present kidney disease treatment study - Investing.com India
Climb Bio to present kidney disease treatment study By Investing.com - Investing.com UK
Eliem Therapeutics Inc [ELYM] Shares Fall -0.97 % on Wednesday - Knox Daily
Eliem Therapeutics mounts corporate rebrand after pipeline overhaul, mass layoffs - FiercePharma
Eliem Therapeutics rebrands to Climb Bio, shifts focus to immune diseases - Investing.com
Eliem Therapeutics Changes Name to Climb Bio - Yahoo Finance
Eliem Therapeutics to change corporate name to Climb Bio - TipRanks
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc. - The Manila Times
Healthy Upside Potential: Eliem Therapeutics Inc (ELYM) - SETE News
Monitoring Eliem Therapeutics Inc (ELYM) after recent insider movements - Knox Daily
Eliem Therapeutics Inc (ELYM) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
Ratio Analysis: Unpacking Eliem Therapeutics Inc (ELYM)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Eliem Therapeutics, Inc. (NASDAQ:ELYM) Stock Position Decreased by Driehaus Capital Management LLC - MarketBeat
Selling Eliem Therapeutics Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Simply Wall St
Private equity firms who have a significant stake must be disappointed along with institutions after Eliem Therapeutics, Inc.'s (NASDAQ:ELYM) market cap dropped by US$231m - Yahoo Finance
Eliem Therapeutics Inc (ELYM) can make a big difference with a little luck - SETE News
Eliem Therapeutics Inc (ELYM) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Affinity Asset Advisors LLC Takes $11.88 Million Position in Eliem Therapeutics, Inc. (NASDAQ:ELYM) - MarketBeat
Trading (ELYM) With Integrated Risk Controls - Stock Traders Daily
500,000 Shares in Eliem Therapeutics, Inc. (NASDAQ:ELYM) Acquired by Ally Bridge Group NY LLC - MarketBeat
Eliem Therapeutics: Recent Strategic Pipeline Restructuring (NASDAQ:ELYM) - Seeking Alpha
Closing Figures: Eliem Therapeutics Inc (ELYM)’s Positive Finish at 8.43, Up 1.81 - The Dwinnex
Eliem Therapeutics Inc (ELYM)’s stock price in review: A technical analysis - US Post News
Eliem therapeutics executive sells over $9,000 in company stock By Investing.com - Investing.com Australia
Eliem therapeutics executive sells over $9,000 in company stock - Investing.com
(ELYM) Trading Signals - Stock Traders Daily
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - GlobeNewswire
Eliem Therapeutics (NASDAQ:ELYM) Trading Up 4.6% - MarketBeat
大文字化:
|
ボリューム (24 時間):